CALIPER LIFE SCIENCES (NASDAQ: CALP)





$3.14 -0.01 (-0.32%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
3.60
52-Week Low Price
0.76
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.15 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.18
Shares
49.03 M
Dividend Rate ($) / (%)
0.00/0.00
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 109% - CALP has outperformed the S&P 500 by 83%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
MOVADO GROUP INC CL CM (MOV) $10.77 -  $0.32(3.06%)0.19 B
LA BARGE INC (LB) $10.60 -  $0.04(0.41%)0.17 B
HERLEY INDUSTRIES INC (HRLY) $11.90 -  $0.10(0.85%)0.16 B
PHOTOMEDEX; INC. (PHMDD) $10.05 -  $0.94(8.55%)0.16 B
NANOMETRICS INC (NANO) $8.48 -  $0.31(3.79%)0.16 B
NEOPROBE CORP (NEOP) $2.20 -  $0.17(8.37%)0.15 B
HEALTHTRONICS INC (HTRN) $2.84 -  $0.02(0.71%)0.13 B
INTERNAT ISOTOPES INC (INIS) $0.42 -  $0.00(0.00%)0.13 B
ROCKWELL MEDICAL TECHS (RMTI) $7.24 -  $0.01(0.14%)0.12 B
EXFO ELECTRO-OPTICAL ENG (EXFO) $5.26 -  $0.10(1.94%)0.12 B
STOCK ANALYSIS
There are currently no Stock Analysis.
CALP RELATED HEADLINES
arrow
Caliper Life Sciences' Third Quarter 2008 Financial Results Conference Call Notice
MONDAY, November 10, 2008 5:00 p.m. EST

Forbes.com 10/23/2008
arrow
Caliper Life Sciences Announces Availability of More Than 200 Kinase Assays in Ready-to-Use Profiling Kits
- Same Day Results Enable Researchers to Make Better Decisions about Which Compounds to Synthesize Next, Accelerating Drug Discovery Programs -

Forbes.com 9/2/2008
arrow
Caliper Life Sciences Receives $1.1 Million Task Order from the EPA's ToxCast(TM) Screening Program
- Caliper Screens Compounds to Detect Toxicity -

Forbes.com 8/19/2008
arrow
A Nifty Arbitrage Play
<ul> <li>Launch of the Genome Analyzer II (GAII)</li> <li>Making DNA by hand</li> <li>Gaining a better understanding of gene expression and Epigenetics</li> </ul>

Wall Street Media 8/7/2008
arrow
Caliper Life Sciences Reports Second Quarter 2008 Results
- Revenue in Line with Company Estimates Highlighted by 11% Discovery Products and Services Growth -

Forbes.com 8/6/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2